Susquehanna International Group
RARE icon

Susquehanna International Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Susquehanna International Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Buy
524,798
+372,482
+245% +$8.39M ﹤0.01% 2979
2025
Q4 		$3.5M Sell
152,316
-81,810
-35% -$2.69M ﹤0.01% 4602
2025
Q3 		$7.04M Buy
234,126
+153,903
+192% +$4.62M ﹤0.01% 3557
2025
Q2 		$2.92M Sell
80,223
-40,237
-33% -$1.45M ﹤0.01% 5016
2025
Q1 		$4.36M Sell
120,460
-59,965
-33% -$2.49M ﹤0.01% 3916
2024
Q4 		$7.59M Buy
180,425
+60,088
+50% +$2.98M ﹤0.01% 2992
2024
Q3 		$6.68M Buy
120,337
+95,466
+384% +$4.86M ﹤0.01% 3141
2024
Q2 		$1.02M Sell
24,871
-24,079
-49% -$1.03M ﹤0.01% 6534
2024
Q1 		$2.29M Buy
48,950
+13,409
+38% +$633K ﹤0.01% 5032
2023
Q4 		$1.7M Sell
35,541
-91,516
-72% -$3.55M ﹤0.01% 5706
2023
Q3 		$4.53M Buy
127,057
+16,393
+15% +$650K ﹤0.01% 3705
2023
Q2 		$5.1M Buy
110,664
+37,951
+52% +$1.76M ﹤0.01% 3497
2023
Q1 		$2.92M Buy
72,713
+58,324
+405% +$2.5M ﹤0.01% 4387
2022
Q4 		$667K Sell
14,389
-77,300
-84% -$3.04M ﹤0.01% 7140
2022
Q3 		$3.8M Buy
91,689
+88,154
+2,494% +$4.53M ﹤0.01% 3615
2022
Q2 		$211K Sell
3,535
-16,318
-82% -$1M ﹤0.01% 10507
2022
Q1 		$1.44M Sell
19,853
-7,508
-27% -$522K ﹤0.01% 6233
2021
Q4 		$2.3M Buy
27,361
+10,289
+60% +$837K ﹤0.01% 5188
2021
Q3 		$1.54M Sell
17,072
-85,845
-83% -$7.76M ﹤0.01% 6408
2021
Q2 		$9.81M Buy
102,917
+93,594
+1,004% +$9.75M ﹤0.01% 2939
2021
Q1 		$1.06M Sell
9,323
-3,566
-28% -$485K ﹤0.01% 7582
2020
Q4 		$1.78M Sell
12,889
-819
-6% -$97.2K ﹤0.01% 5327
2020
Q3 		$1.13M Sell
13,708
-28,174
-67% -$2.34M ﹤0.01% 5819
2020
Q2 		$3.28M Sell
41,882
-48,907
-54% -$3.24M ﹤0.01% 3648
2020
Q1 		$4.03M Buy
90,789
+20,942
+30% +$1.09M ﹤0.01% 2856
2019
Q4 		$2.98M Sell
69,847
-8,276
-11% -$341K ﹤0.01% 3710
2019
Q3 		$3.34M Buy
78,123
+30,548
+64% +$1.66M ﹤0.01% 3312
2019
Q2 		$3.02M Buy
+47,575
New +$3.03M ﹤0.01% 3435
2019
Q1 		– Sell
-38,270
Closed -$2.19M – 9655
2018
Q4 		$1.66M Buy
38,270
+6,736
+21% +$368K ﹤0.01% 3799
2018
Q3 		$2.41M Buy
+31,534
New +$2.56M ﹤0.01% 3706
2018
Q2 		– Sell
-33,536
Closed -$2.17M – 10248
2018
Q1 		$1.71M Sell
33,536
-58,792
-64% -$2.96M ﹤0.01% 4222
2017
Q4 		$4.28M Buy
+92,328
New +$4.53M ﹤0.01% 2721
2017
Q1 		– Sell
-61,894
Closed -$4.72M – 9761
2016
Q4 		$4.35M Buy
+61,894
New +$4.39M ﹤0.01% 2643
2016
Q3 		– Sell
-27,563
Closed -$1.76M – 8909
2016
Q2 		$1.35M Sell
27,563
-17,577
-39% -$1.14M ﹤0.01% 4257
2016
Q1 		$2.86M Buy
45,140
+36,426
+418% +$2.38M ﹤0.01% 3132
2015
Q4 		$978K Sell
8,714
-1,470
-14% -$147K ﹤0.01% 5439
2015
Q3 		$981K Buy
10,184
+605
+6% +$69.3K ﹤0.01% 5799
2015
Q2 		$981K Buy
+9,579
New +$744K ﹤0.01% 6258
2014
Q3 		– Sell
-4,602
Closed -$232K – 9845
2014
Q2 		$207K Buy
+4,602
New +$189K ﹤0.01% 9002

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Susquehanna International Group's RARE Position: Q1 2026 in Review

Susquehanna International Group increased its Ultragenyx Pharmaceutical (RARE) stake by 245% in Q1 2026, buying an estimated $8.39M and bringing the position to 524,798 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

Susquehanna International Group first reported a position in RARE in Q2 2014 and has held it in 39 quarters since. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Susquehanna International Group held 524,798 shares of Ultragenyx Pharmaceutical worth $11M as of Q1 2026.
  • Susquehanna International Group bought 372,482 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $8.39M.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2979 holding.
  • Susquehanna International Group first reported a position in Ultragenyx Pharmaceutical in Q2 2014 and has held it in 39 quarters since.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.